J Korean Neurol Assoc.  2009 Feb;27(1):13-18.

Change of Serum Neuron Specific Enolase Level During Acute Stage of Cerebral Infarction

Affiliations
  • 1Department of Neurology, Kwandong University College of Medicine, Gyeonggi-do, Korea.
  • 2Department of Neurology, KyungHee University School of Medicine, Seoul, Korea. kcneuro@dreamwiz.com

Abstract

BACKGROUND
Neuron-specific enolase (NSE) is a useful indicator of neuronal injury in acute cerebral infarction. We investigated the changes in serial serum NSE levels in patients with acute cerebral infarction.
METHODS
We measured serial serum NSE levels at 24, 48, 72, and 96 hours, and 2 weeks after the onset of cerebral infarction in 30 patients (15 territorial and 15 lacunar infarctions). We also measured the NSE levels in age-matched controls (n=15) who had no evidence of acute stroke or other neurological disorders. The NSE level was measured using a radioimmunoassay.
RESULTS
The initial serum NSE level was significantly higher in the cerebral infarction group than in the control group (6.6+/-2 vs 4.7+/-1.6 ng/mL [mean+/-SD], p=0.006). This difference was also observed between the territorial and lacunar infarction groups until 72 hours after the cerebral infarction. The serum NSE level peaked at 72 hours after the infarction in both lacunar and territorial infarction groups. The correlation between the NSE level and the score on the NIH Stroke Scale was strongest at 48 hours after the cerebral infarction (r=0.469).
CONCLUSIONS
Serum NSE level can be a good indicator for distinguishing lacunar from territorial infarction during the acute stage of cerebral infarction.

Keyword

Neuron-specific enolase; Acute cerebral infarction

MeSH Terms

Cerebral Infarction
Humans
Infarction
Nervous System Diseases
Neurons
Phosphopyruvate Hydratase
Stroke
Stroke, Lacunar
Phosphopyruvate Hydratase
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr